REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lakpue Drug Inc. (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Lakpue Drug Inc. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lakpue Drug Inc. is an enterprise in Philippines, with the main office in Quezon City. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on August 27, 1986. In 2023, the company reported a net sales revenue drop of 14.45%. There was a total growth of 23.83% in Lakpue Drug Inc.’s total assets over the same period.

Headquarters
24 Ldi Bldg, 12Th Ave
Quezon City; National Capital Region;

Contact Details: Purchase the Lakpue Drug Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Lakpue Drug Inc. report to view the information.
Incorporation Date:
August 27, 1986
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Lakpue Drug Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-14.45%▼
Total operating revenue
-14.45%▼
Operating profit (EBIT)
168.93%▲
EBITDA
168.93%▲
Net Profit (Loss) for the Period
N/A
Total Assets
23.83%▲
Total Equity
6.98%▲
Operating Profit Margin (ROS)
3.78%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
28.37%▲
Quick Ratio
-0.12%▼
Cash Ratio
-0.03%▼

Similar companies

Zuellig Pharma Corporation
 
Unilever Philippines, Inc.
Unilab Inc
 
Metro Drug Inc
Abbott Laboratories Philippines Inc
 
Wyeth Philippines, Inc.
Iraseth Pharma Inc.
 
Pharmahex, Inc.
Esmart Drug Mindoro Corp.
 
Interchemex Laboratories, Inc.
9 Ace Global Technologies Inc.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo